CYC
CYCLOPHARM FPO [CYC]
Healthcare · ASX Small Cap
$0.5100 +0.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-03-04
Get alerts when CYC triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Low cash runway (3 quarters) - dilution risk
- Low P/S ratio (1.9x)
- Moderate revenue growth (+14%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (7% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (25%)
- Sentiment is mixed — no strong consensus either way
- Beneish M-Score -0.29 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
- Calendar: Clinical Trial in 6d (+5pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-53%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.63%/day)
Expected next for CYC
Window: 1 Jul to 31 Dec
From a company announcement on 25 Feb 2026
The last 1 moved CYC +1.5% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE Cyclopharm 1H 2026 Results Webinar
NONE CYC 1H2026 Results Summary
NONE Half Yearly Report and Accounts
Recent ASX Announcements
| 2026-08-23 | Cyclopharm 1H 2026 Results Webinar |
| 2026-08-23 | CYC 1H2026 Results Summary PRICE SENSITIVE |
| 2026-08-23 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-07-28 | New US Lung Imaging Guidelines Name Technegas as Preferred A PRICE SENSITIVE |
| 2026-07-27 | ausbiz TV Presentation |
Key Metrics
$64.1M
Market Cap
56K
Avg Volume
1.3x
Vol Ratio
$0.45 — $1.29
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-53.9%
ROE
-53.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 51% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | pass | Inst: 25% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track CYC and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required